Holly LaDuca

13PUBLICATIONS
85CO-AUTHORS
Cancer geneticsMedical molecular engineering of nucleic acids and proteinsMedical biotechnology diagnostics (incl. biosensors)Epigenetics (incl. genome methylation and epigenomics)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Oct 01, 2026
Point-of-care models for genetic testing among patients at risk of hereditary cancer: A systematic review.

|May 30, 2023
Functional and Clinical Characterization of Variants of Uncertain Significance Identifies a Hotspot for Inactivating Missense Variants in RAD51C.

Chunling Hu, Anil Belur Nagaraj, Hermela Shimelis

|Aug 12, 2022
Development and Validation of the PREMMplus Model for Multigene Hereditary Cancer Risk Assessment.

Matthew B Yurgelun, Hajime Uno, C Sloane Furniss

|May 23, 2022
Clinician-Reported Impact of Germline Multigene Panel Testing on Cancer Risk Management Recommendations.

Carolyn Horton, Kirsten Blanco, Min-Tzu Lo

|Jan 07, 2022
Different Fumarate Hydratase Gene Variants Are Associated With Distinct Cancer Phenotypes.

Junne Kamihara, Carrie Horton, Yuan Tian

|Oct 30, 2021
Classification of the canonical splice alteration MUTYH c.934-2A > G is likely benign based on RNA and clinical data.

Felicia Hernandez, Blair R Conner, Marcy E Richardson

Pageof 3

Frequent Collaborators

6 joint publications

Tina Pesaran

5 joint publications

Steven N Hart

5 joint publications

Amal Yussuf

5 joint publications

Jill S Dolinsky